PureTech Health PLC (PRTC)
29.62
+0.12
(+0.41%)
USD |
NASDAQ |
May 23, 10:28
PureTech Health Price to Book Value: 1.728 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 1.721 |
| May 21, 2024 | 1.721 |
| May 20, 2024 | 1.673 |
| May 17, 2024 | 1.673 |
| May 16, 2024 | 1.673 |
| May 15, 2024 | 1.661 |
| May 14, 2024 | 1.604 |
| May 13, 2024 | 1.604 |
| May 10, 2024 | 1.600 |
| May 09, 2024 | 1.600 |
| May 08, 2024 | 1.600 |
| May 07, 2024 | 1.600 |
| May 06, 2024 | 1.596 |
| May 03, 2024 | 1.659 |
| May 02, 2024 | 1.630 |
| May 01, 2024 | 1.625 |
| April 30, 2024 | 1.625 |
| April 29, 2024 | 1.658 |
| April 26, 2024 | 1.658 |
| April 25, 2024 | 1.598 |
| April 24, 2024 | 1.598 |
| April 23, 2024 | 1.521 |
| April 22, 2024 | 1.521 |
| April 19, 2024 | 1.521 |
| April 18, 2024 | 1.567 |
| Date | Value |
|---|---|
| April 17, 2024 | 1.567 |
| April 16, 2024 | 1.482 |
| April 15, 2024 | 1.482 |
| April 12, 2024 | 1.574 |
| April 11, 2024 | 1.625 |
| April 10, 2024 | 1.620 |
| April 09, 2024 | 1.620 |
| April 08, 2024 | 1.628 |
| April 05, 2024 | 1.634 |
| April 04, 2024 | 1.728 |
| April 03, 2024 | 1.626 |
| April 02, 2024 | 1.616 |
| April 01, 2024 | 1.745 |
| March 28, 2024 | 1.658 |
| March 27, 2024 | 1.667 |
| March 26, 2024 | 1.710 |
| March 25, 2024 | 1.673 |
| March 22, 2024 | 1.602 |
| March 21, 2024 | 1.602 |
| March 20, 2024 | 1.629 |
| March 19, 2024 | 1.651 |
| March 18, 2024 | 1.504 |
| March 15, 2024 | 1.488 |
| March 14, 2024 | 1.488 |
| March 13, 2024 | 1.501 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.906
Minimum
Dec 07 2023
2.732
Maximum
Mar 29 2021
1.679
Average
1.519
Median
Feb 20 2024
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.64 |
| iBio Inc | 0.7214 |
| Theriva Biologics Inc | 0.1877 |
| Oragenics Inc | 10.52 |
Price to Book Value Related Metrics
| PS Ratio | 481.70 |
| Price | 29.62 |
| Earnings Yield | -8.10% |
| Market Cap | 801.99M |